Amgen (AMGN)

Other Income/Expenses (Net)

-$2.36B

TTM · Period ending: · USD

AMGN logo

AMGN Other Income/Expenses (Net)

Latest reported-$2.36B
AMGN TTM Other Income/Expenses (Net) (-$4.70M → -$2.36B)
High-resolution chart · PNG

AMGN other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Amgen Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
247,600,000
292,900,000
263,900,000
294,200,000
249,100,000
213,300,000
241,200,000
214,200,000
146,300,000
126,900,000
106,000,000
99,900,000
-58,400,000
-65,300,000
-68,900,000
-77,800,000
66,100,000
67,800,000
61,200,000
60,900,000
51,500,000
41,400,000
33,600,000
-90,000,000
-94,100,000
-105,300,000
-110,100,000
10,700,000
10,900,000
33,500,000
41,100,000
42,100,000
66,600,000
60,900,000
64,900,000
64,500,000
50,900,000
41,300,000
34,600,000
30,700,000
24,800,000
21,200,000
14,500,000
9,500,000
4,000,000
500,000
65,100,000
42,500,000
22,000,000
4,800,000
-13,600,000
-5,900,000
900,000
5,600,000
-17,100,000
-11,300,000
-4,800,000
1,300,000
-4,700,000
-2,000,000
-3,400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.